Efficiency of neoajuvant polychemoterapy of patients having urinary bladder carcinoma and the traits of muscular invasion

E.A. Usynin, E.G. Grigoryev, E.M. Slonimskaya, L.V. Spirina
Keywords: invasive bladder cancer, neoadjuvant chemotherapy, survival, efficacy
Medicinskij al'manah, 2015, issue 2, pages 61-63.

The purpose of the present research was influence studying neoadjuvant MVAC (cisplatin, methotrexate,

vinblastin, doxorubicin) on efficacy of treatment muscle invasive bladder cancer. Neoadjuvant chemotherapy

in patients with muscle invasive bladder cancer reduces quantity of local recurrence, enlarges

lifetime and reduces quantity of carried out radical cystectomy.

1. Matveev B.P., Figurin K.M., Korjakin O.B. Rak mochevogo puzyrja. M.

2001. 243 s.

2.Pereverzev A.S., Petrov S.B. Lechenie raka mochevogo puzyrja. M.

2002. S. 8-9.

3. Chissov V.I. Izbrannye lekcii po klinicheskoj onkologii. M. 2000. S. 578-579.

4.Mikich D.H. Organosohranjajushhee lechenie pri invazivnom rake

mochevogo puzyrja. Onkourologija. 2005. № 2. S. 27-31.

5.Karjakin O.B., Popov A.M. Neoad#juvantnaja himioterapija raka mochevogo

puzyrja: za i protiv. Onkourologija. 2006. № 2. S. 31-34.

6.Popov A.M., Karjakin O.B. Organosohranjajushhee lechenie invazivnogo

raka mochevogo puzyrja. Rossijskij onkologicheskij zhurnal. 2005. № 3.

S. 49-52.

7.Bolotina L.V., Rusakov I.G. Invazivnyj rak mochevogo puzyrja: sovremennye

podhody k lecheniju. Rossijskij onkologicheskij zhurnal. 2007. № 6. S. 47-51.

8. Sternberg C.N. Neo-adjuvant and adjuvant chemotherapy of bladder cancer:

Is there a role? European Society for Medical Oncology. 2002. P. 273-279.

E.A. Usynin, E.G. Grigoryev, E.M. Slonimskaya, L.V. Spirina Efficiency of neoajuvant polychemoterapy of patients having urinary bladder carcinoma and the traits of muscular invasion. Medicinskij al'manah 2015; (2): 61–63